- American Academy of Dermatology
- Society for Investigative Dermatology
- Dermatology Foundation
- American Society for Clinical Investigation
- American Dermatological Association
- American Association for the Advancement of Science
Kim Yancey, M.D.
- Dermatology - General
- Melanoma
- Skin Cancer
Biography
A native of Georgia, Kim B. Yancey, M.D., is Professor in the Department of Dermatology at UT Southwestern Medical Center. After graduating from the University of Georgia, summa cum laude and valedictorian, he earned his medical degree (Alpha Omega Alpha) from the Medical College of Georgia and performed his residency training there.
A National Institutes of Health-funded researcher for more than 25 years, Dr. Yancey completed a postdoctoral fellowship in immunodermatology in the Dermatology Branch of the National Cancer Institute at the National Institutes of Health (NIH). He is certified by the American Board of Dermatology, and also holds special competence in Dermatologic Immunology and Diagnostic Laboratory Immunology.
In 1985, Dr. Yancey joined the faculty of the Uniformed Services University of Health Sciences in Bethesda, Maryland as an Assistant Professor of Dermatology and was later promoted to Associate Professor, serving as Acting Chairman from 1990 to 1993. At the Uniformed Services University he was the only dermatologist on the full-time faculty, with responsibilities primarily related to investigative work. He also provided clinical services as a supervising physician at Walter Reed Army Medical Center, Bethesda Naval Hospital, and the National Institutes of Health.
Further pursuing his interest in biomedical investigation, Dr. Yancey re-joined the Dermatology Branch of the National Cancer Institute in 1993 as a Tenured Senior Investigator at the NIH. His NIH laboratory focused on mechanisms of keratinocyte adhesion to epidermal basement membrane and the pathophysiologic basis of autoimmune and inherited blistering diseases.
In 2001, Dr. Yancey was invited to join the faculty of the Medical College of Wisconsin (MCW) in Milwaukee as Professor and Chair of the Department of Dermatology. He divided his time among clinical, teaching, research, and administrative responsibilities at MCW, Froedtert Hospital, and the Zablocki Veterans Affairs Medical Center.
Dr. Yancey joined UT Southwestern in 2007 as Professor and Chair of the Department of Dermatology. His professional efforts focus on research, clinical care, education, administrative activities, and directing a team of over 25 dermatologists.
Dr. Yancey is a member of the American Society for Clinical Investigation, the Society for Investigative Dermatology, the Dermatology Foundation, the American Academy of Dermatology, the American Dermatological Association, and numerous other professional organizations. He is a former Director and Vice President of the American Board of Dermatology, a former President of the Society for Investigative Dermatology, a former Deputy Editor of the Journal of Investigative Dermatology, the current President of the Dermatology Foundation, a member of the Board of Directors of the Association of Professors of Dermatology, and a member of several editorial boards.
He was included in D Magazine's Best Doctors list for 2018, 2020, 2021, and 2022. In 2007, he received the American Academy of Dermatology’s Marion Sulzberger Award.
He has published numerous research manuscripts, monographs, and chapters, served on an array of grant review panels, and presented more than 150 scientific abstracts and invited lectures in the U.S. and abroad.
Meet Dr. Yancey
Dr. Kim Yancey’s path as a physician scientist began far away from Dallas, culminating here after years of advanced medical training, excellence in biomedical investigation and teaching, and the care of thousands of patients.
Before coming to Dallas, he was Chair of the dermatology department at the Medical College of Wisconsin, a smaller department and medical center, but with activities similar to UTSW.
“The opportunity here – not just in the Department of Dermatology, but in the greater institution itself – was quite unique, with its significant resources, robust community, and a trajectory toward growth and development in both clinical and basic sciences,” says Dr. Yancey, who was Chair of UT Southwestern's Department of Dermatology until 2023.
For Dr. Yancey, coming here was an opportunity to take a strong department to an even higher level.
“This department has been strong for several reasons, including its core academic strength as demonstrated by publications, grants, and scholarly activities; its solid cohort of clinicians who provide excellent care to patients; and its very creative residency training program with a track record of creating leaders in dermatology. We’ve been able to build on these traditional elements to further strengthen the department,” Dr. Yancey says.
Dr. Yancey believes that one of the novel aspects of UTSW’s dermatology department is having physicians with expertise in selected areas.
“They use that expertise in the clinic, then carry those observations and experiences back to their laboratory, where they pursue research that impacts patient care. Accordingly, the department is recognized as a resource to the greater community,” he says.
"I want our patients to know they will be seen by a caring, compassionate physician who will give them direct responses to their concerns, and who is embedded in a care network that will be able to support them."
Education & Training
- Medical School - Medical College of Georgia/Georgia Regents University (1974-1978)
- Fellowship - National Institutes of Health Clinical Center (1981-1985), Immunodermatology
- Residency - Medical College of Georgia (1979-1981), Dermatology
- Internship - Medical College of Georgia (1978-1979), Internal Medicine
- Other Post Graduate Training - National Institutes of Health (1981-1982)
Professional Associations & Affiliations
Honors & Awards
- D Magazine Best Doctor, 2018, 2020 – 2022
- President, Dermatology Foundation (2017 to date)
- Board of Directors, Association of Professors of Dermatology (2015 to date)
- President, Society for Investigative Dermatology (2011-2012)
- Board of Directors, Dermatology Foundation (2008 to date)
- Deputy Editor, Journal of Investigative Dermatology (2007-2010)
- Board of Directors, Society for Investigative Dermatology (2004-2009)
- Sulzberger Award and Lecture, American Academy of Dermatology (2007)
- Vice President, American Board of Dermatology (2005)
- Director, American Board of Dermatology (1997-2005)
Books & Publications
-
Publications
-
West Nile virus encephalitis presenting with a vesicular dermatitis
Lee EE, Mejia M, Matthews LA, Lee F, Shah KM, Schoggins JW, Vandergriff TW, Yancey KB, Thomas C, Wang RC JAAD Case Reports 2024 Mar 45 117-122 -
Tumoral melanosis: A case series of patients with metastatic melanoma after systemic immunotherapy
Wix SN, Heberton M, Vandergriff TW, Yancey KB, Gill JG JAAD Case Reports 2024 Mar 45 82-87 -
The Biology of the Basement Membrane
Yancey KB 2024 Jan 1 491-500 -
Clinical and Serological Characterization of Orf-Induced Immunobullous Disease
Yilmaz K, Goletz S, Pas HH, Van Den Bos RR, Blauvelt A, White WL, Bouaziz JD, Zuelgaray E, Daneshpazhooh M, Yancey KB, Goebeler M, Schmidt E JAMA Dermatology 2022 Jun 158 670-674 -
Trends in dermatology eponyms
He L, Cornish TC, Kricka LJ, Vandergriff TW, Yancey K, Nguyen K, Park JY JAAD International 2022 Jun 7 137-143 -
Dapsone-responsive inflammatory dermatitis with features of subcorneal pustular dermatosis and bullous pemphigoid
Ghatnekar S, Rutherford A, Vandergriff T, Yancey KB JAAD Case Reports 2022 Jun 24 29-31 -
Training Physician‒Scientists for Careers in Investigative Dermatology
Li S, Yancey KB, Cruz PD, Le LQ JID Innovations 2022 Jan 2 -
A cross-sectional survey and analysis of Dermatology Foundation Career Development Award recipients
Boris C, Cotsarelis G, Fairley JA, Wintroub BU, Yancey KB Journal of the American Academy of Dermatology 2019 Nov 81 1093-1098 -
A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid
Goletz S, Probst C, Komorowski L, Schlumberger W, Fechner K, van Beek N, Holtsche MM, Recke A, Yancey K, Hashimoto T, Antonicelli F, Di Zenzo G, Zillikens D, Stöcker W, Schmidt E British Journal of Dermatology 2019 Jan 180 149-156 -
Commentary regarding: Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. H Lal, AL Cunningham, O Godeaux et al., N Engl J Med 372:2087–2096, 2015
Yancey KB Dermatologic Therapy 2016 Sep 29 300-301 -
Commentary regarding: Effectiveness of saltwater baths in the treatment of epidermolysis bullosa
Yancey KB Dermatologic Therapy 2016 Mar 29 136 -
Commentary regarding: A randomized trial of icatibant in ACE-inhibitor-induced angioedema
Yancey KB Dermatologic Therapy 2015 Sep 28 331 -
Itch, eosinophils, and autoimmunity: A novel murine model of bullous pemphigoid
Yancey KB Journal of Investigative Dermatology 2015 May 135 1213-1215 -
Detection of type VII collagen autoantibodies before the onset of bullous systemic lupus erythematosus
Grabell DA, Matthews LA, Yancey KB, Chong BF JAMA Dermatology 2015 May 151 539-543 -
Commentary regarding clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: A randomized, comparative, observer-blinded study
Yancey KB Dermatologic Therapy 2015 May 28 174-175 -
Commentary regarding double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria by M Morgan, A Cooke, L Rogers, B Adams-Huet, da Khan. J Allergy Clin Immunol Pract 2:601-606, 2014
Yancey KB Dermatologic Therapy 2015 Mar 28 102-103 -
Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts
Murrell DF, Marinovic B, Caux F, Prost C, Ahmed R, Wozniak K, Amagai M, Bauer J, Beissert S, Borradori L, Culton D, Fairley JA, Fivenson D, Jonkman MF, Marinkovich MP, Woodley D, Zone J, Aoki V, Bernard P, Bruckner-Tuderman L, Cianchini G, Venning V, Diaz L, Eming R, Grando SA, Hall RP, Hashimoto T, Herrero-González JE, Hertl M, Joly P, Karpati S, Kim J, Chan Kim S, Korman NJ, Kowalewski C, Lee SE, Rubenstein DR, Sprecher E, Yancey K, Zambruno G, Zillikens D, Doan S, Daniel BS, Werth VP Journal of the American Academy of Dermatology 2015 Jan 72 168-174 -
Commentary: Omalizumab therapy for bullous pemphigoid by KK Yu, AB Crew, KAN Messingham, JA Fairley, DT Woodley. J Am Acad Dermatol 2014 Jun 20. pii: S0190-9622(14)01410-8. doi: 10.1016/j.jaad.2014.04.053. [Epub ahead of print]
Yancey KB Dermatologic Therapy 2015 Jan 28 3 -
Skin Lesions Associated with Gastrointestinal and Liver Diseases
Vandergriff TW, Yancey KB 2015 Jan 2440-2458 -
Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid
Yancey KB Dermatologic Therapy 2014 Nov 27 315 -
Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins
Yancey KB Dermatologic Therapy 2014 Sep 27 311 -
Differential expression of BAFF and its receptors in discoid lupus erythematosus patients
Chong BF, Tseng Lc, Kim A, Miller RT, Yancey KB, Hosler GA Journal of Dermatological Science 2014 Mar 73 216-224 -
Anti-laminin-332 mucous membrane pemphigoid in a 9-year old girl
Kahn E, Spence Shishido A, Yancey KB, Lawley LP Pediatric dermatology 2014 31 e76-e79 -
IgG, IgM, and IgA antinuclear antibodies in discoid and systemic lupus erythematosus patients
Jost SA, Tseng LC, Matthews LA, Vasquez R, Zhang S, Yancey KB, Chong BF The Scientific World Journal 2014 2014 -
Pathomechanistic paradigms in autoimmune blistering diseases
Aubert P, Yancey KB Drug Discovery Today: Disease Mechanisms 2013 Dec 10 e95-e100 -
Pattern ichthyosis in a newborn
Cayce R, Word AP, Agim N, Yancey KB Pediatric dermatology 2013 Sep 30 621-622 -
The dermatology foundation: Partnerships and programs focused on the future
Fairley JA, Krueger GG, Lessin SR, Leyden JJ, McBurney EI, Orlow SJ, Tharp MD, Voorhees JJ, Wintroub BU, Yancey KB Journal of Investigative Dermatology 2013 Apr 133 861-862 -
Happy birthday, society for investigative dermatology
Pentland AP, Hall RP, Yancey KB Journal of Investigative Dermatology 2012 Mar 132 495 -
A retrospective analysis of the dermatology foundation's career development award program
Boris C, Lessin SR, Wintroub BU, Yancey KB Journal of the American Academy of Dermatology 2012 67 969-974 -
Therapeutic Approaches to Patients with Mucous Membrane Pemphigoid
Kourosh AS, Yancey KB Dermatologic Clinics 2011 Oct 29 637-641 -
Iododerma following radioactive iodine ablation of the thyroid for graves disease
Vandergriff TW, Yancey KB Journal of Drugs in Dermatology 2011 Sep 10 1070-1071 -
A noduloulcerative disease that still lingers after all these centuries
Cayce R, Yancey KB Journal of Drugs in Dermatology 2011 Sep 10 1072-1073 -
Pathogenesis of mucous membrane pemphigoid
Kourosh AS, Yancey KB Dermatologic Clinics 2011 Jul 29 479-484 -
Hair follicle stem cells provide a functional niche for melanocyte stem cells
Tanimura S, Tadokoro Y, Inomata K, Binh NT, Nishie W, Yamazaki S, Nakauchi H, Tanaka Y, McMillan JR, Sawamura D, Yancey K, Shimizu H, Nishimura EK Cell Stem Cell 2011 Feb 8 177-187 -
Tender erythematous plaques on the legs
Tran KT, Hughes S, Cockerell CJ, Yancey KB Clinical and Experimental Dermatology 2010 Apr 35 e65-e66 -
Sequential intramolecular epitope spreading of humoral responses to human BPAG2 in a transgenic model
Di Zenzo G, Calabresi V, Olasz EB, Zambruno G, Yancey KB Journal of Investigative Dermatology 2010 Apr 130 1040-1047 -
Non-Herlitz Junctional Epidermolysis Bullosa
Yancey KB, Hintner H Dermatologic Clinics 2010 Jan 28 67-77 -
A novel humanized neonatal autoimmune blistering skin disease model induced by maternally transferred antibodies
Nishie W, Sawamura D, Natsuga K, Shinkuma S, Goto M, Shibaki A, Ujiie H, Olasz E, Yancey KB, Shimizu H Journal of Immunology 2009 Sep 183 4088-4093 -
Transient anti-CD40L co-stimulation blockade prevents immune responses against human bullous pemphigoid antigen 2: Implications for gene therapy
Lanschuetzer CM, Olasz EB, Lazarova Z, Yancey KB Journal of Investigative Dermatology 2009 May 129 1203-1207 -
Complement system
Yancey KB, Lazarova Z 2008 Dec 105-118 -
Segmental odontomaxillary dysplasia presenting with facial hypertrichosis, commissural lip clefting, and hyperlinear palms
Koenig LJ, Lynch DP, Yancey KB Pediatric dermatology 2008 Jul 25 491-492 -
IgG anti-laminin-332 autoantibodies are present in a subset of patients with mucous membrane, but not bullous, pemphigoid
Lazarova Z, Salato VK, Lanschuetzer CM, Janson M, Fairley JA, Yancey KB Journal of the American Academy of Dermatology 2008 Jun 58 951-958 -
Introduction to the milestones in autoimmune bullous diseases
Yancey KB, Fairley JA The Journal of investigative dermatology 2008 128 E15 -
Bullous pemphigoid and related subepidermal autoimmune blistering diseases
Olasz E, Yancey K Current Directions in Autoimmunity 2008 10 141-166 -
Orf-induced immunobullous disease: A distinct autoimmune blistering disorder
White KP, Zedek DC, White WL, Simpson EL, Hester E, Morrison L, Lazarova Z, Liu D, Scagliarini A, Kurtz SE, White CR, Yancey KB, Blauvelt A Journal of the American Academy of Dermatology 2008 Jan 58 49-55 -
Two cases of anti-epiligrin cicatricial pemphigoid with and without associated malignancy
Fukushima S, Egawa K, Nishi H, Wakasugi S, Ishii N, Hashimoto T, Yancey KB, Ihn H Acta Dermato-Venereologica 2008 88 484-487 -
Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild-type mice
Olasz EB, Roh J, Yee CL, Arita K, Akiyama M, Shimizu H, Vogel JC, Yancey KB Journal of Investigative Dermatology 2007 Dec 127 2807-2817 -
A widening perspective regarding the relationship between anti-epiligrin cicatricial pemphigoid and cancer
Sadler E, Lazarova Z, Sarasombath P, Yancey KB Journal of Dermatological Science 2007 Jul 47 1-7 -
Humanization of autoantigen
Nishie W, Sawamura D, Goto M, Ito K, Shibaki A, McMillan JR, Sakai K, Nakamura H, Olasz E, Yancey KB, Akiyama M, Shimizu H Nature medicine 2007 Mar 13 378-383 -
Cutaneous Crohn's disease mimicking Melkersson-Rosenthal syndrome: Treatment with methotrexate
Tonkovic-Capin V, Galbraith SS, Rogers RS, Binion DG, Yancey KB Journal of the European Academy of Dermatology and Venereology 2006 Apr 20 449-452 -
CD200, a "no danger" signal for hair follicles
Rosenblum MD, Yancey KB, Olasz EB, Truitt RL Journal of Dermatological Science 2006 Mar 41 165-174 -
IgG autoantibodies to type VII collagen and an exclusive IgG3 reactivity to the laminin α3 chain in a patient with an autoimmune subepidermal blistering disease
Baican A, Hirako Y, Lazarova Z, Yancey KB, Zillikens D, Sitaru C Journal of the American Academy of Dermatology 2005 Sep 53 516-521 -
The pathophysiology of autoimmune blistering diseases
Yancey KB Journal of Clinical Investigation 2005 Apr 115 825-828 -
Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoid
Lazarova Z, Sitaru C, Zillikens D, Yancey KB Journal of the American Academy of Dermatology 2004 Dec 51 886-892 -
Expression of CD200 on epithelial cells of the murine hair follicle: A role in tissue-specific immune tolerance?
Rosenblum MD, Olasz EB, Yancey KB, Woodliff JE, Lazarova Z, Gerber KA, Truitt RL Journal of Investigative Dermatology 2004 Nov 123 880-887 -
A Case of Anti-Epiligrin Cicatricial Pemphigoid Associated with Lung Carcinoma and Severe Laryngeal Stenosis: Review of Japanese Cases and Evaluation of Risk for Internal Malignancy
Matsushima S, Horiguchi Y, Honda T, Fujii S, Okano T, Tanabe M, Wakayama T, Hashimoto T, Yancey KB Journal of Dermatology 2004 Jan 31 10-15 -
Anti-epiligrin cicatricial pemphigoid clinical findings, immunopothogenesis, and significant associations
Egan CA, Lazarova Z, Darling TN, Yee C, Yancey KB Medicine 2003 May 82 177-186 -
Anti-epiligrin cicatricial pemphigoid and epidermolysis bullosa acquisita: Differentiation by use of indirect immunofluorescence microscopy
Vodegel RM, De Jong MC, Pas HH, Yancey KB, Jonkman MF Journal of the American Academy of Dermatology 2003 Apr 48 542-547 -
Development of spliceosome-mediated RNA trans-splicing (SMaRT™) for the correction of inherited skin diseases
Dallinger G, Puttaraju M, Mitchell LG, Yancey KB, Yee C, Klausegger A, Hintner H, Bauer JW Experimental Dermatology 2003 Feb 12 37-46 -
BP180 (type XVII collagen) and its role in cutaneous biology and disease
Van Den Bergh F, Giudice GJ, Yancey KB Advances in dermatology 2003 19 37-71 -
Pathogenesis of acne: Recent research advances
Harper JC, Thiboutot DM, Yancey KB Advances in dermatology 2003 19 1-10 -
Photobiology and phototherapeutics
Kerr HA, Lim HW, Yancey KB Advances in dermatology 2003 19 11-36 -
Antiepiligrin cicatricial pemphigoid of the larynx successfully treated with a combination of tetracycline and niacinamide
Sakamoto K, Mori K, Hashimoto T, Yancey KB, Nakashima T Archives of Otolaryngology - Head and Neck Surgery 2002 Dec 128 1420-1423 -
Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease
Szabolcs P, Reese M, Yancey KB, Hall RP, Kurtzberg J Bone Marrow Transplantation 2002 Sep 30 327-329 -
Anti-p200 pemphigoid: Diagnosis and treatment of a case presenting as an inflammatory subepidermal blistering disease
Egan CA, Yee C, Zillikens D, Yancey KB Journal of the American Academy of Dermatology 2002 May 46 786-789 -
Comprehensive analysis of gene expression profiles in keratinocytes from patients with generalized atrophic benign epidermolysis bullosa
Huber A, Yee C, Darling TN, Yancey KB Experimental Dermatology 2002 Feb 11 75-81 -
Cicatricial pemphigoid: Immunopathogenesis and treatment
Lazarova Z, Yancey KB Dermatologic Therapy 2002 15 382-388 -
The first international consensus on mucous membrane pemphigoid: Definition, diagnostic criteria, pathogenic factors, medical treatment and prognostic indicators
Chan LS, Razzaque Ahmed A, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, Fine JD, Stephen Foster C, Ghohestani R, Hashimoto T, Hoang-Xuan T, Kirtschig G, Korman NJ, Lightman S, Lozada-Nur F, Peter Marinkovich M, Mondino BJ, Prost-Squarcioni C, Rogers RS, Setterfield JF, West DP, Wojnarowska F, Woodley DT, Yancey KB, Zillikens D, Zone JJ Archives of Dermatology 2002 138 370-379 -
Anti-epiligrin cicatricial pemphigoid and relative risk for cancer
Egan CA, Lazarova Z, Darling TN, Yee C, Coté T, Yancey KB Lancet 2001 Jun 357 1850-1851 -
Treatment of epidermolysis bullosa acquisita with the humanized anti-Tac mAb daclizumab
Egan CA, Brown M, White JD, Yancey KB Clinical Immunology 2001 101 146-151 -
IgG autoantibodies in patients with anti-epiligrin cicatricial pemphigoid recognize the G domain of the laminin 5 α-subunit
Lazarova Z, Yee C, Lazar J, Yancey KB Clinical Immunology 2001 101 100-105 -
The hSkn-1a POU transcription factor enhances epidermal stratification by promoting keratinocyte proliferation
Hildesheim J, Kühn U, Yee CL, Foster RA, Yancey KB, Vogel JC Journal of cell science 2001 114 1913-1923 -
Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180
Schmidt E, Skrobek C, Kromminga A, Hashimoto T, Messer G, Bröcker EB, Yancey KB, Zillikens D British Journal of Dermatology 2001 145 778-783 -
Pemphigoid: Clinical, histologic, immunopathologic, and therapeutic considerations
Yancey KB, Egan CA JAMA 2000 Jul 284 350-356 -
Subepidermal blistering disease with autoantibodies against a novel dermal 200-kDa antigen
Kawahara Y, Zillikens D, Yancey KB, Marinkovich MP, Nie Z, Hashimoto T, Nishikawa T Journal of Dermatological Science 2000 Jun 23 93-102 -
Fab fragments directed against laminin 5 induce subepidermal blisters in neonatal mice
Lazarova Z, Hsu R, Briggaman RA, Yancey KB Clinical Immunology 2000 Apr 95 26-32 -
Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin α3
Jonkman MF, Schuur J, Dijk F, Heeres K, De Jong MC, Van Der Meet JB, Yancey KB, Pas HH Archives of Dermatology 2000 Feb 136 227-231 -
Human anti-laminin 5 autoantibodies induce subepidermal blisters in an experimental human skin graft model
Lazarova Z, Hsu R, Yee C, Yancey KB Journal of Investigative Dermatology 2000 114 178-184 -
The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis
Roh JY, Yee C, Lazarova Z, Hall RP, Yancey KB British Journal of Dermatology 2000 143 104-111 -
The clinical and immunopathological manifestations of anti-epiligrin cicatricial pemphigoid, a recently defined subepithelial autoimmune blistering disease
Egan CA, Yancey KB European Journal of Dermatology 2000 10 585-589 -
Antiepiligrin cicatricial pemphigoid: An underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases?
Leverkus M, Schmidt E, Lazarova Z, Bröcker EB, Yancey KB, Zillikens D Archives of Dermatology 1999 Sep 135 1091-1098 -
Mucosal morbidity in patients with epidermolysis bullosa acquisita
Luke MC, Darling TN, Hsu R, Summers RM, Smith JA, Solomon BI, Thomas GR, Yancey KB Archives of Dermatology 1999 Aug 135 954-959 -
Revertant mosaicism: Partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation
Darling TN, Yee C, Bauer JW, Hintner H, Yancey KB Journal of Clinical Investigation 1999 May 103 1371-1377 -
Anti-epiligrin cicatricial pemphigoid with antibodies against the γ2 subunit of laminin 5
Nousari HC, Rencic A, Hsu R, Yancey KB, Anhalt GJ Archives of Dermatology 1999 Feb 135 173-176 -
Anti-epiligrin cicatricial pemphigoid with IgG autoantibodies to the β and γ subunits of laminin 5
Fujimoto W, Toi Y, Okazaki F, Lazarova Z, Yancey KB, Arata J Journal of the American Academy of Dermatology 1999 40 637-639 -
IgG and IgA antibodies in linear IgA/IgG bullous dermatosis target the ectodomain of bullous pemphigoid antigen 2 [2]
Hertl M, Budinger L, Christophoridis S, Yancey KB, Borradori L British Journal of Dermatology 1999 140 750-752 -
Antiepiligrin (Laminin 5) cicatricial pemphigoid associated with an underlying gastric carcinoma producing laminin 5
Taniuchi K, Takata M, Matsui C, Fushida Y, Uchiyama K, Mori T, Kawara S, Yancey KB, Takehara K British Journal of Dermatology 1999 140 696-700 -
Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls
Büdinger L, Borradori L, Yee C, Eming R, Ferencik S, Grosse-Wilde H, Merk HF, Yancey K, Hertl M Journal of Clinical Investigation 1998 Dec 102 2082-2089 -
Anti-epiligrin cicatricial pemphigoid: A case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita
Fujimoto W, Ishida-Yamamoto A, Hsu R, Nagao Y, Hzuka H, Yancey KB, Arata J British Journal of Dermatology 1998 Oct 139 682-687 -
Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid
Murakami H, Nishioka S, Setterfield J, Bhogal BS, Black MM, Zillikens D, Yancey KB, Balding SD, Giudice GJ, Diaz LA, Nishikawa T, Kiyokawa C, Hashimoto T Journal of Dermatological Science 1998 May 17 39-44 -
Cycloheximide facilitates the identification of aberrant transcripts resulting from a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosa
Darling TN, Yee C, Koh B, McGrath JA, Bauer JW, Uitto J, Hintner H, Yancey KB Journal of Investigative Dermatology 1998 110 165-169 -
Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2
Haase C, Büdinger L, Borradori L, Yee C, Merk HF, Yancey K, Hertl M Journal of Investigative Dermatology 1998 110 282-286 -
Vernarbendes pemphigoid mit autoantikorpern gegen laminin-5 (epiligrin) bei einer patientin mit metastasierendem endometriumkarzinom
Lenz P, Hsu R, Yee C, Yancey K, Volc-Platzer B, Stingl G, Kirnbauer R Hautarzt 1998 Jan 49 31-35 -
Localization of the extracellular domain of BPAG2 in human epidermal basement membrane [2]
Yancey KB, Yee C Journal of Investigative Dermatology 1998 110 302 -
Antiepiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5 (α3β3γ2)
Lazarova Z, Hsu R, Yee C, Yancey KB British Journal of Dermatology 1998 139 791-797 -
A case of cicatricial pemphigoid with simultaneous IgG autoantibodies against the 180 kd bullous pemphigoid antigen and laminin 5
Kawahara Y, Amagai M, Ohata Y, Ishii K, Hasegawa Y, Hsu R, Yee C, Yancey KB, Nishikawa T Journal of the American Academy of Dermatology 1998 38 624-627 -
97 kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180 kDa bullous pemphigoid antigen
Ishiko A, Shimizu H, Masunaga T, Yancey KB, Giudice GJ, Zone JJ, Nishikawa T Journal of Investigative Dermatology 1998 111 93-96 -
A deletion mutation in COL17A1 in five Austrian families with generalized atrophic benign epidermolysis bullosa represents propagation of an ancestral allele
Darling TN, Koh BB, Bale SJ, Compton JG, Bauer JW, Hintner H, Yancey KB Journal of Investigative Dermatology 1998 110 170-173 -
Noncomplement fixing, IgG4 autoantibodies predominate in patients with anti-epiligrin cicatricial pemphigoid
Hsu R, Lazarova Z, Yee C, Yancey KB Journal of Investigative Dermatology 1997 109 557-561 -
Premature termination codons are present on both alleles of the bullous pemphigoid antigen 2/ Type XVII collagen gene in five Austrian families with generalized atrophic benign epidermolysis bullosa
Darling TN, McGrath JA, Yee C, Gatalica B, Hametner R, Bauer JW, Pohla-Gubo G, Christiano AM, Uitto J, Hintner H, Yancey KB Journal of Investigative Dermatology 1997 108 463-468 -
Generalized atrophic benign epidermolysis bullosa.
Darling TN, Bauer JW, Hintner H, Yancey KB Advances in dermatology 1997 13 87-119; discussion 120 -
The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of normal human epidermal basement membrane
Masunaga T, Shimizu H, Yee C, Borradori L, Lazarova Z, Nishikawa T, Yancey KB Journal of Investigative Dermatology 1997 109 200-206 -
Anti-epiligrin cicatricial pemphigoid in a patient with HIV
Lish KM, Washenik K, Yancey KB, Yee C, Rico MJ Journal of the American Academy of Dermatology 1997 36 486-488 -
Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice
Lazarova Z, Yee C, Darling T, Briggaman RA, Yancey KB Journal of Clinical Investigation 1996 Oct 98 1509-1518 -
Antiepiligrin cicatricial pemphigoid: The first case report from Japan
Hashimoto T, Murakami H, Senboshi Y, Kanzaki H, Arata J, Yancey KB, Nishikawa T Journal of the American Academy of Dermatology 1996 May 34 940-942 -
Advances in the diagnosis of subepidermal bullous diseases
Yancey KB, Hintner H Archives of Dermatology 1996 132 220-222 -
A homozygous deletion mutation in the gene encoding the 180-kDa bullous pemphigoid antigen (BPAG2) in a family with generalized atrophic benign epidermolysis bullosa
McGrath JA, Darling T, Gatalica B, Pohla-Gubo G, Hintner H, Christiano AM, Yancey K, Uitto J Journal of Investigative Dermatology 1996 106 771-774 -
A Child with Antibodies Targeting Both Linear IgA Bullous Dermatosis and Bullous Pemphigoid Antigens
Darling TN, Cardenas AA, Beard JS, Sau P, Yee CL, Zone JJ, Yancey KB Archives of Dermatology 1995 Dec 131 1438-1442 -
Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in the epidermal basement membrane of patients with generalized atrophic benign epidermolysis bullosa
Pohla-Gubo G, Lazarova Z, Giudice GJ, Liebert M, Grassegger A, Hintner H, Yancey KB Experimental Dermatology 1995 Aug 4 199-206 -
Epiligrin is decreased in papulonodular basal cell carcinoma tumor nest basement membranes and the extracellular matrix of transformed human epithelial cells
Lazarova Z, Domloge-Hultsch N, Yancey KB Experimental Dermatology 1995 Jun 4 121-129 -
Passive Transfer of Autoantibodies From a Patient With Mutilating Epidermolysis Bullosa Acquisita Induces Specific Alterations in the Skin of Neonatal Mice
Borradori L, Caldwell JB, Briggaman RA, Burr CE, Gammon WR, James WD, Yancey KB Archives of Dermatology 1995 May 131 590-595 -
Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the α subunit of laminin 5
Kirtschig G, Marinkovich MP, Burgeson RE, Yancey KB Journal of Investigative Dermatology 1995 105 543-548 -
Studies of patients with anti-epiligrin cicatricial pemphigoid
Yancey KB, Kirtschig G, Yee C, Lazarova Z Journal of Dermatology 1995 22 829-835 -
Autoantibodies from patients with cicatricial pemphigoid target different sites in epidermal basement membrane
Shimizu H, Masunaga T, Ishiko A, Matsumura K, Hashimoto T, Nishikawa T, Domloge-Hultsch N, Lazarova Z, Yancey KB Journal of Investigative Dermatology 1995 104 370-373 -
Adhesion molecules. II: Interactions of keratinocytes with epidermal basement membrane
Yancey KB Journal of Investigative Dermatology 1995 104 1008-1014 -
Antiepiligrin Cicatricial Pemphigoid: A Subepithelial Bullous Disorder
Domloge-Hultsch N, Anhalt GJ, Gammon WR, Lazarova Z, Briggaman R, Welch M, Jabs DA, Huff C, Yancey KB Archives of Dermatology 1994 Dec 130 1521-1529 -
From Bedside to Bench and Back: The Diagnosis and Biology of Bullous Diseases
Yancey KB Archives of Dermatology 1994 Aug 130 983-987 -
Epidermolysis bullosa acquisita: Efficacy of high-dose intravenous immunoglobulins
Caldwell JB, Yancey KB, Engler RJ, James WD, Meier F, Sonnichsen K, Schaumburg-Lever G, Dopfer R, Rassner G Journal of the American Academy of Dermatology 1994 Jan 31 827-828 -
C3d,g deposits in inflammatory skin diseases: Use of psoriatic skin as a model of cutaneous inflammation
Basset-Séguin N, Porneuf M, Dereure O, Mils V, Tesnières A, Yancey KB, Guilhou JJ Journal of Investigative Dermatology 1993 Dec 101 827-831 -
Immune-Mediated Subepithelial Blistering Diseases of Mucous Membranes: Pure Ocular Cicatricial Pemphigoid Is a Unique Clinical and Immunopathological Entity Distinct From Bullous Pemphigoid and Other Subsets Identified by Antigenic Specificity of Autoantibodies
Chan LS, Yancey KB, Hammerberg C, Soong HK, Regezi JA, Johnson K, Cooper KD Archives of Dermatology 1993 Apr 129 448-455 -
Erratum: Fragments de clivage du C3 et la jonction dermo-epidermique de la peau humaine normale (Ann Dermatol Venereol 1992; 119: 629-34)
Basset-Seguin N, Yancey KB Annales de Dermatologie et de Venereologie 1993 120 171 -
Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease
Domloge-Hultsch N, Gammon WR, Briggaman RA, Gil SG, Carter WG, Yancey KB Journal of Clinical Investigation 1992 Oct 90 1628-1633 -
A Bullous Skin Disease Patient With Autoantibodies Against Separate Epitopes in 1 mol/L Sodium Chloride Split Skin
Domloge-Hultsch N, Benson P, Gammon WR, Yancey KB Archives of Dermatology 1992 Aug 128 1096-1101 -
Childhood Localized Vulvar Pemphigoid Is a True Variant of Bullous Pemphigoid
Saad RW, Domloge-Hultsch N, Yancey KB, Benson PM, James WD Archives of Dermatology 1992 Jun 128 807-810 -
Human keratinocytes and A-431 cells synthesize and secrete factor B, the major zymogen protease of the alternative complement pathway
Yancey KB, Overholser O, Domloge-Hultsch N, Li LJ, Wright Caughman S, Bisalbutra P Journal of Investigative Dermatology 1992 Mar 98 379-383 -
Waldenström Macroglobulinemia with an IgM-κ Antiepidermal Basement Membrane Zone Antibody
Cobb MW, Domloge-Hultsch N, Frame JN, Yancey KB Archives of Dermatology 1992 Mar 128 372-376 -
FRAGMENTS DE CLIVAGE DU C3 ET LA JONCTION DERMO-EPIDERMIQUE DE LA PEAU HUMAINE NORMALE
Basset-Seguin N, Yancey KB Annales de Dermatologie et de Venereologie 1992 Jan 119 629-634 -
C5a, cutaneous mast cells, and inflammation: In vitro and in vivo studies in a murine model
Lim HW, He D, Esquenazi-Behar S, Yancey KB, Soter NA Journal of Investigative Dermatology 1991 Aug 97 305-311 -
Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin
Domloge-Hultsch N, Bisalbutra P, Gammon WR, Yancey KB Journal of the American Academy of Dermatology 1991 24 946-951 -
A-431 cells and human keratinocytes synthesize and secrete the third component of complement
Basset-Séguin N, Wright Caughman S, Yancey KB Journal of Investigative Dermatology 1990 Dec 95 621-625 -
Autoantibodies From Patients with Localized and Generalized Bullous Pemphigoid Immunoprecipitate the Same 230-kd Keratinocyte Antigen
Domloge-Hultsch N, Utecht L, James W, Yancey KB Archives of Dermatology 1990 Oct 126 1337-1341 -
Studies of C3d,g in normal human epidermal basement membrane
Yancey KB, Basset-Séguin N Journal of Investigative Dermatology 1990 Jun 94 S122-S127 -
Reply
Swerlick RA, Yancey KB, Lawley TJ Journal of Investigative Dermatology 1990 Apr 94 499 -
C3d,g In normal human epidermal basement membrane (I)
Basset-Seguin N, Yancey KB Acta Dermato-Venereologica 1990 70 273 -
Herpes gestationis
Yancey KB Dermatologic Clinics 1990 8 727-735 -
Inflammatory properties of human C5a and C5a des Arg in mast cell-depleted human skin (I: Reply)
Swerlick RA, Yancey KB, Lawley TJ Journal of Investigative Dermatology 1990 Jan 94 -
Inflammatory properties of human C5a and C5a des Arg/ in mast cell-depleted human skin
Swerlick RA, Yancey KB, Lawley TJ Journal of Investigative Dermatology 1989 Sep 93 417-422 -
Generation of C5-dependent bioactivity by tissue-bound anti-BMZ autoantibodies
Gammon WR, Yancey KB, Mangum KL, Hendrix JD, Hammer CH Journal of Investigative Dermatology 1989 Aug 93 195-200 -
Defective expression of basement membrane-associated C3d,g in papulonodular basal cell carcinomas
Basset-Séguin N, Uhle P, Emanuel D, Henry P, Yancey KB Journal of Investigative Dermatology 1989 May 92 734-738 -
Analysis of the interaction of human C5a and C5a des arg with human monocytes and neutrophils: Flow cytometric and chemotaxis studies
Yancey KB, Lawley TJ, Dersookian M, Harvath L Journal of Investigative Dermatology 1989 Feb 92 184-189 -
Differential release of mediators from human basophils: Differences in arachidonic acid metabolism following activation by unrelated stimuli
Warner JA, Peters SP, Lichtenstein LM, Hubbard W, Yancey KB, Stevenson HC, Miller PJ, MacGlashan DW Journal of Leukocyte Biology 1989 45 558-571 -
Role of C5a in the induction of tumoricidal activity in C3H/HeJ (Lps(d)) and C3H/OuJ (Lps(n)) macrophages
Hogan MM, Yancey KB, Vogel SN Journal of Leukocyte Biology 1989 46 565-570 -
C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro: Comparison with secretion of interleukin Iβ and interleukin lα
Okusawa S, Yancey KB, Van der Meer JW, Endres S, Lonnemann G, Hefter K, Frank MM, Burke JF, Dinarello CA, Gelfand JA Journal of Experimental Medicine 1988 Jul 168 443-448 -
C3d,g is present in normal human epidermal basement membrane
Basset-Seguin N, Dersookian M, Cehrs K, Yancey KB Journal of Immunology 1988 141 1273-1280 -
A direct in vivo comparison of the inflammatory properties of human C5a and C5a des Arg in human skin
Swerlick RA, Yancey KB, Lawley TJ Journal of Immunology 1988 140 2376-2381 -
Biological properties of human C5a: selected in vitro and in vivo studies
Yancey KB Clinical and Experimental Immunology 1988 71 207-210 -
Patients with bone marrow failure demonstrate decreased cutaneous reactivity to human C5a
Yancey KB, Bielory L, Wright R, Young N, Frank MM, Lawley TJ Journal of Investigative Dermatology 1987 Apr 88 388-392 -
C5a as a mediator of cutaneous inflammation
Yancey KB, Swerlick RA, Lawley TJ American Journal of Dermatopathology 1987 9 138-143 -
C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-γ
Okusawa S, Dinarello CA, Yancey KB, Endres S, Lawley TJ, Frank MM, Burke JF, Gelfand JA Journal of Immunology 1987 139 2635-2640 -
Immediate hypersensitivity
Keahey TM, Yancey KB, Lawley TJ Journal of the American Academy of Dermatology 1987 17 826-837 -
The effect of pertussis toxin on mediator release from human basophils
Warner JA, Yancey KB, MacGlashan DW Journal of Immunology 1987 139 161-165 -
A simplified method for purification of human C5a from citrated plasma
Renfer L, Frank MM, Hammer CH, Harvath L, Lawley TJ, Yancey KB Journal of Immunological Methods 1986 Apr 88 193-205 -
Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones
Harvath L, Yancey KB, Katz SI Journal of Immunology 1986 137 1305-1311 -
Effectiveness of cyclosporin therapy for Beh¸let's disease
Nussenblatt RB, Palestine AG, Chan CC, Mochizuki M, Yancey K Arthritis & Rheumatism 1985 Jun 28 671-679 -
Serum Sickness
Matthews JW, Belmont HM, Dent PB, Lawley TJ, Yancey KB, Bielory L, Young N, Gascon P, Frank MM New England Journal of Medicine 1985 May 312 1327-1328 -
Studies of human C5a as a mediator of inflammation in normal human skin
Yancey KB, Hammer CH, Harvath L, Renfer L, Frank MM, Lawley TJ Journal of Clinical Investigation 1985 75 486-495 -
Human C5a modulates monocyte Fc and C3 receptor expression
Yancey KB, O'Shea J, Chused T, Brown E, Takahashi T, Frank MM, Lawley TJ Journal of Immunology 1985 135 465-470 -
Cutaneous manifestations of serum sickness in patients receiving antithymocyte globulin
Bielory L, Yancey KB, Young NS, Frank MM, Lawley TJ Journal of the American Academy of Dermatology 1985 13 411-417 -
A study of human serum sickness
Lawley TJ, Bielory L, Gascon P, Yancey KB, Young NS, Frank MM Journal of Investigative Dermatology 1985 85 S129-S132 -
A Prospective Clinical and Immunologic Analysis of Patients with Serum Sickness
Lawley TJ, Bielory L, Gascon P, Yancey KB, Young NS, Frank MM New England Journal of Medicine 1984 Nov 311 1407-1413 -
Duplicate Publications (?)-Reply
Rogers RB, Yancey KB, Allen BS Archives of Dermatology 1984 Aug 120 992 -
Circulating immune complexes: Their immunochemistry, biology, and detection in selected dermatologic and systemic diseases
Yancey KB, Lawley TJ Journal of the American Academy of Dermatology 1984 10 711-731 -
Pruritic urticarial papules and plaques of pregnancy: Clinical experience in twenty-five patients
Yancey KB, Hall RP, Lawley TJ Journal of the American Academy of Dermatology 1984 10 473-480 -
Human serum sickness.
Lawley TJ, Bielory L, Gascon P, Yancey KB, Young NS, Frank MM Transactions of the Association of American Physicians 1984 97 49-55 -
Studies on the fibronectin receptors of human peripheral blood leukocytes: Morphologic and functional characterization
Pommier CG, O'Shea J, Chused T, Yancey K, Frank MM, Takahashi T, Brown EJ Journal of Experimental Medicine 1984 Jan 159 137-151 -
Phenytoin Therapy for Junctional Epidermolysis Bullosa
Rogers RB, Yancey KB, Allen BS, Guill MF Archives of Dermatology 1983 Nov 119 925-926 -
Junctional Epidermolysis Bullosa: Treatment With Phenytoin
Guill MF, Wray BB, Rogers RB, Yancey KB, Allen BS American Journal of Diseases of Children 1983 Oct 137 992-994 -
Circulating immune complexes and dermatologic diseases
Yancey KB, Lawley TJ American Journal of Dermatopathology 1983 Jan 5 401-405 -
Dietary gluten challenge does not influence the levels of circulating immune complexes in patients with dermatitis herpetiformis
Yancey KB, Cason JC, Hall RP, Lawley TJ Journal of Investigative Dermatology 1983 80 468-471 -
Georgia's most common skin cancer: basal cell carcinoma.
Yancey KB, Guill MA Journal of the Medical Association of Georgia 1982 Jan 71 19-21 -
Interferon
Smith JG, Yancey KB Southern medical journal 1980 Aug 73 963-964 -
Status of puva therapy
Yancey KB, Graham Smith J Southern medical journal 1980 Feb 73 132-133 -
Interferon: Status in treatment of skin disease
Yancey KB, Smith JG Journal of the American Academy of Dermatology 1980 3 585-595
-
West Nile virus encephalitis presenting with a vesicular dermatitis
Research
- Inherited blistering diseases (i.e., epidermolysis bullosa)
- Autoimmune blistering diseases
- Animal models of skin disease
Clinical Focus
- Melanoma
- Skin Cancer
Q&A by Dr. Yancey
Results: 1 Locations
Dermatology Clinic
at Professional Office Building 2 5939 Harry Hines Blvd., 4th Floor, Suite 100Dallas, Texas 75390 214-645-2400 Directions to Dermatology Clinic at Professional Office Building 2, Dallas Parking Info for Dermatology Clinic